Filing Details
- Accession Number:
- 0000899243-21-033814
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-20 16:10:12
- Reporting Period:
- 2021-08-18
- Accepted Time:
- 2021-08-20 16:10:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1805890 | Fusion Pharmaceuticals Inc. | FUSN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643085 | Steven Gannon | C/O Fusion Pharmaceuticals, Inc., 2 International Place, Suite 2310 Boston MA 02110 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-18 | 171 | $8.05 | 6,171 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-19 | 3,000 | $8.05 | 9,171 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
